Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas

NCT02238496 is registered in ClinicalTrials.gov with Andrew B Lassman, MD as lead sponsor.

NCT NCT02238496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas
Lead sponsor
Andrew B Lassman, MD
Phase
Phase 1
Overall status
Completed
Start date
December 8, 2014
Completion date
February 14, 2021
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligodendroglioma, brain tumor, recurrent, glioblastoma, mixed glioma